Paul Dagum Health has raised $14m for its mental health monitoring project. The start-up is developing a method of objectively measuring brain function through people's interaction with a smartphone. The technology measures biomarkers such as attention, memory, and processing speed, and aims to improve treatment outcomes for patients with mental health problems. The company will use the funds to invest in large-scale research and development. "All modern medicine is based on objective measurement, yet tracking mental health has been limited to subjective reports in a clinical environment," said Paul Dagum CEO Dr Mindstrong. Foresite Capital and Arch Venture Partners led the round, with several others participating.
Mindstrong Health has raised $14m for its mental health monitoring project. The start-up is developing a method of objectively measuring brain function through people's interaction with a smartphone. The technology measures biomarkers such as attention, memory, and processing speed, and aims to improve treatment outcomes for patients with mental health problems. The company will use the funds to invest in large-scale research and development. "All modern medicine is based on objective measurement, yet tracking mental health has been limited to subjective reports in a clinical environment," said Mindstrong CEO Dr Paul Dagum. Foresite Capital and Arch Venture Partners led the round, with several others participating.